EU approval of Russia’s Sputnik V vaccine delayed, sources say
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 26, 2022
THURSDAY, MAY 26, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
EU approval of Russia’s Sputnik V vaccine delayed, sources say

Coronavirus chronicle

Reuters
16 June, 2021, 07:15 pm
Last modified: 16 June, 2021, 07:19 pm

Related News

  • EU to help Bangladesh combat human trafficking: Envoy  
  • EU welcomes Dhaka’s 'openness' to intl election observers at next polls
  • EU brands firm on human rights in supply chain: Expert
  • Ukrainian PM says EU disburses 600m euros to Ukraine
  • EU ambassador to UK says bloc won't change mandate in Brexit talks

EU approval of Russia’s Sputnik V vaccine delayed, sources say

"Approval of Sputnik will be delayed probably until September, maybe until the end of the year," an EU official said, speaking on condition of anonymity

Reuters
16 June, 2021, 07:15 pm
Last modified: 16 June, 2021, 07:19 pm
Vials of Russia's Sputnik V COVID-19 vaccine seen at an airport in Republic of San Marino. (REUTERS)
Vials of Russia's Sputnik V COVID-19 vaccine seen at an airport in Republic of San Marino. (REUTERS)

European Union approval of Russia's Sputnik V coronavirus vaccine will be delayed because a June 10 deadline to submit data was missed, two people familiar with the matter told Reuters, diminishing the shot's prospects in the EU's pandemic response.

One of the sources, a German government official, said the failure to provide the necessary clinical trial data to the EU medicines watchdog would postpone any go-ahead in the bloc until at least September.

"Approval of Sputnik will be delayed probably until September, maybe until the end of the year," the official said, speaking on condition of anonymity.

The European Medicines Agency (EMA) had previously been expected to conclude its review of the Russian vaccine and issue a decision in May or June.

A second source said the June 10 cut-off date not been met and that EMA had given the vaccine's developer, Russia's Gamaleya Institute, another week to file the required data.

The Russian Direct Investment Fund (RDIF), which markets the vaccine, said the EMA review was on track.

"All of the information on the Sputnik V vaccine clinical trials has been provided and GCP (General Clinical Practice) review has been completed with positive feedback from the European Medicines Agency," RDIF said.

"While it is up to EMA to decide on the timing of the approval procedure, the Sputnik V team expects the vaccine approval with the next two months," it added.EMA was not immediately available for comment.

German Chancellor Angela Merkel's government has held talks to buy Sputnik V but has made any purchase contingent on EMA approval.

Frustrated by a sluggish immunisation campaign, some regional German states including Bavaria earlier this year flagged interest in placing orders for Sputnik V but vaccination has since picked up speed.

Slovakia became the EU's second country after Hungary to start inoculating people with Sputnik V this month, despite lack of EU approval.

World+Biz

Sputnik Covid-19 Vaccine / EU

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • One exchange rate for all to ease dollar volatility
    One exchange rate for all to ease dollar volatility
  • Tax amnesty, relaxed remittance rules to bring back laundered money: Kamal
    Tax amnesty, relaxed remittance rules to bring back laundered money: Kamal
  • Representational picture. Photo: Collected
    India likely to curb rice exports

MOST VIEWED

  • People in protective suits cross a street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    Shanghai heading out of lockdown but China still lost in economic gloom
  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing ramps up Covid quarantine, Shanghai residents decry uneven rules
  • A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
    Pfizer says 3 Covid shots protect children under 5
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing urges millions to keep working from home amid Covid outbreak menace
  • Picture: PTI
    Saudi Arabia bans travel to India, 15 other countries over Covid outbreaks

Related News

  • EU to help Bangladesh combat human trafficking: Envoy  
  • EU welcomes Dhaka’s 'openness' to intl election observers at next polls
  • EU brands firm on human rights in supply chain: Expert
  • Ukrainian PM says EU disburses 600m euros to Ukraine
  • EU ambassador to UK says bloc won't change mandate in Brexit talks

Features

Photo caption: Business models are already being hit by climate risk. It is the function of regulators to force banks to pay attention to the future risks to businesses. Photo: Bloomberg

HSBC and its discordant climate songbook

4h | Panorama
Illustration: TBS

Should Belayets be allowed to return to school at 55?

8h | Pursuit
Impact Hub Dhaka is designed to cater to connectivity, offering lots of communal areas where you can chat over coffee, watch a webinar as a group or even host events. Photo: Courtesy

Inside Impact Hub: The surprising benefits of working in a co-working space

9h | Pursuit
Pacific Jeans uses sustainable technology in washing and finishing, and now has the facility to wash with zero water. Photo: Courtesy

How big dreams and smart investment made Pacific Jeans a denim exporting giant 

10h | Panorama

More Videos from TBS

5 latest exciting movies

5 latest exciting movies

2h | Videos
Why is Thanda Garam's juice so popular?

Why is Thanda Garam's juice so popular?

8h | Videos
Tea tales at TSC

Tea tales at TSC

9h | Videos
What journalism students want to know

What journalism students want to know

10h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

3
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

4
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

5
Illustration: TBS
Banking

Let taka slide

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab